Life ScienceCompany
Hyperion Therapeutics M&A Summary
Hyperion Therapeutics has acquired 1 company of its own.
Hyperion Therapeutics’ largest acquisition to date was in 2014, when it acquired Andromeda Biotech for $13M. The Company’s most targeted sectors include life science (100%).
Hyperion Therapeutics Ownership
Who owns Hyperion Therapeutics?
Hyperion Therapeutics is owned by Horizon Therapeutics Public Limited Company. It was acquired on April 3, 2015.
Was Hyperion Therapeutics formerly PE-backed?
Yes. Hyperion Therapeutics was formerly owned by 1 private investor.
Hyperion Therapeutics Business Overview
Where is Hyperion Therapeutics headquartered?
Hyperion Therapeutics is headquartered in Brisbane, California.
What sector is Hyperion Therapeutics in?
Hyperion Therapeutics is a life science company.
When was Hyperion Therapeutics founded?
Hyperion Therapeutics was founded in 2006.
M&A Summary
-
M&A Total Activity1
- M&A Buy Activity1
- Total Sectors Invested 1
- Total Countries Invested 1